{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:39:27Z","timestamp":1791257967278,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T00:00:00Z","timestamp":1346976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2012.35","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T13:22:43Z","timestamp":1347024163000},"page":"e88-e88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Waldenstr\u00f6m\u2019s macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders"],"prefix":"10.1038","volume":"2","author":[{"given":"A","family":"Perrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pionneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Baillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F M","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Merle-B\u00e9ral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"B\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bahram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Vallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,7]]},"reference":[{"key":"BFbcj201235_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1200\/JCO.2005.03.144","volume":"23","author":"MA Dimopoulos","year":"2005","unstructured":"Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP . Diagnosis and management of Waldenstrom\u2019s macroglobulinemia. J Clin Oncol 2005; 23: 1564\u20131577.","journal-title":"J Clin Oncol"},{"key":"BFbcj201235_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol 2003; 30: 110\u2013115.","journal-title":"Semin Oncol"},{"key":"BFbcj201235_CR3","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood.V83.12.3647.3647","volume":"83","author":"SD Wagner","year":"1994","unstructured":"Wagner SD, Martinelli V, Luzzatto L . Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood 1994; 83: 3647\u20133653.","journal-title":"Blood"},{"key":"BFbcj201235_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3816\/CLM.2005.n.002","volume":"5","author":"J Kriangkum","year":"2005","unstructured":"Kriangkum J, Taylor BJ, Reiman T, Belch AR, Pilarski LM . Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor? Clin Lymphoma 2005; 5: 217\u2013219.","journal-title":"Clin Lymphoma"},{"key":"BFbcj201235_CR5","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1182\/blood-2003-11-4024","volume":"104","author":"J Kriangkum","year":"2004","unstructured":"Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM . Clonotypic IgM V\/D\/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood 2004; 104: 2134\u20132142.","journal-title":"Blood"},{"key":"BFbcj201235_CR6","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V100.4.1505.h81602001505_1505_1507","volume":"100","author":"SS Sahota","year":"2002","unstructured":"Sahota SS, Forconi F, Ottensmeier CH, Provan D, Oscier DG, Hamblin TJ et al. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 2002; 100: 1505\u20131507.","journal-title":"Blood"},{"key":"BFbcj201235_CR7","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1182\/blood-2005-09-3613","volume":"107","author":"J Kriangkum","year":"2006","unstructured":"Kriangkum J, Taylor BJ, Strachan E, Mant MJ, Reiman T, Belch AR et al. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Blood 2006; 107: 2920\u20132927.","journal-title":"Blood"},{"key":"BFbcj201235_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553\u2013563.","journal-title":"Cell"},{"key":"BFbcj201235_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nature06020","volume":"449","author":"CT Yan","year":"2007","unstructured":"Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007; 449: 478\u2013482.","journal-title":"Nature"},{"key":"BFbcj201235_CR10","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/MCB.20.9.2996-3003.2000","volume":"20","author":"SA Nick McElhinny","year":"2000","unstructured":"Nick McElhinny SA, Snowden CM, McCarville J, Ramsden DA . Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol Cell Biol 2000; 20: 2996\u20133003.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201235_CR11","doi-asserted-by":"publisher","first-page":"18597","DOI":"10.1073\/pnas.0609061103","volume":"103","author":"PO Mari","year":"2006","unstructured":"Mari PO, Florea BI, Persengiev SP, Verkaik NS, Bruggenwirth HT, Modesti M et al. Dynamic assembly of end-joining complexes requires interaction between Ku70\/80 and XRCC4. Proc Natl Acad Sci USA 2006; 103: 18597\u201318602.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201235_CR12","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2006-02-005488","volume":"108","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006; 108: 2755\u20132763.","journal-title":"Blood"},{"key":"BFbcj201235_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.leu.2404520","volume":"21","author":"NC Gutierrez","year":"2007","unstructured":"Gutierrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Ferminan E et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 2007; 21: 541\u2013549.","journal-title":"Leukemia"},{"key":"BFbcj201235_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/sonc.2003.50066","volume":"30","author":"CS Mitsiades","year":"2003","unstructured":"Mitsiades CS, Mitsiades N, Treon SP, Anderson KC . Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias. Semin Oncol 2003; 30: 156\u2013160.","journal-title":"Semin Oncol"},{"key":"BFbcj201235_CR15","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1158\/0008-5472.CAN-06-3089","volume":"67","author":"E Hatjiharissi","year":"2007","unstructured":"Hatjiharissi E, Ngo H, Leontovich AA, Leleu X, Timm M, Melhem M et al. Proteomic analysis of waldenstrom macroglobulinemia. Cancer Res 2007; 67: 3777\u20133784.","journal-title":"Cancer Res"},{"key":"BFbcj201235_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2011-02-335125","volume":"118","author":"A Perrot","year":"2011","unstructured":"Perrot A, Pionneau C, Nadaud S, Davi F, Leblond V, Jacob F et al. A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia. Blood 2011; 118: e1\u2013e15.","journal-title":"Blood"},{"key":"BFbcj201235_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.copbio.2003.12.001","volume":"15","author":"G Van den Bergh","year":"2004","unstructured":"Van den Bergh G, Arckens L . Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol 2004; 15: 38\u201343.","journal-title":"Curr Opin Biotechnol"},{"key":"BFbcj201235_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.blre.2004.11.003","volume":"19","author":"O Margalit","year":"2005","unstructured":"Margalit O, Somech R, Amariglio N, Rechavi G . Microarray-based gene expression profiling of hematologic malignancies: basic concepts and clinical applications. Blood Rev 2005; 19: 223\u2013234.","journal-title":"Blood Rev"},{"key":"BFbcj201235_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12185-010-0662-1","volume":"92","author":"M Seto","year":"2010","unstructured":"Seto M . Genomic profiles in B cell lymphoma. Int J Hematol 2010; 92: 238\u2013245.","journal-title":"Int J Hematol"},{"key":"BFbcj201235_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O . On the origin of cancer cells. Science 1956; 123: 309\u2013314.","journal-title":"Science"},{"key":"BFbcj201235_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/BF02988499","volume":"15","author":"K Kubota","year":"2001","unstructured":"Kubota K . From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001; 15: 471\u2013486.","journal-title":"Ann Nucl Med"},{"key":"BFbcj201235_CR22","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1111\/j.1742-4658.2011.08178.x","volume":"278","author":"NH Cheng","year":"2011","unstructured":"Cheng NH, Zhang W, Chen WQ, Jin J, Cui X, Butte NF et al. A mammalian monothiol glutaredoxin, Grx3, is critical for cell cycle progression during embryogenesis. FEBS J 2011; 278: 2525\u20132539.","journal-title":"FEBS J"},{"key":"BFbcj201235_CR23","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood.V95.10.3214","volume":"95","author":"H Sakamoto","year":"2000","unstructured":"Sakamoto H, Mashima T, Kizaki A, Dan S, Hashimoto Y, Naito M et al. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 2000; 95: 3214\u20133218.","journal-title":"Blood"},{"key":"BFbcj201235_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature01819","volume":"424","author":"CA Neumann","year":"2003","unstructured":"Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003; 424: 561\u2013565.","journal-title":"Nature"},{"key":"BFbcj201235_CR25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/cdd.2011.21","volume":"18","author":"SY Kim","year":"2011","unstructured":"Kim SY, Chun E, Lee KY . Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ 2011; 18: 1573\u20131583.","journal-title":"Cell Death Differ"},{"key":"BFbcj201235_CR26","first-page":"4841","volume":"56","author":"HL Asch","year":"1996","unstructured":"Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL et al. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 1996; 56: 4841\u20134845.","journal-title":"Cancer Res"},{"key":"BFbcj201235_CR27","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1093\/emboj\/16.15.4650","volume":"16","author":"M Ohtsu","year":"1997","unstructured":"Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S et al. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J 1997; 16: 4650\u20134656.","journal-title":"EMBO J"},{"key":"BFbcj201235_CR28","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/pmic.200500417","volume":"6","author":"NM Verrills","year":"2006","unstructured":"Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M . Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study. Proteomics 2006; 6: 1681\u20131694.","journal-title":"Proteomics"},{"key":"BFbcj201235_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.bbamcr.2010.09.015","volume":"1813","author":"C Enrich","year":"2011","unstructured":"Enrich C, Rentero C, de Muga SV, Reverter M, Mulay V, Wood P et al. Annexin A6-Linking Ca(2+) signaling with cholesterol transport. Biochem Biophys Acta 2011; 1813: 935\u2013947.","journal-title":"Biochem Biophys Acta"},{"key":"BFbcj201235_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1172\/JCI110295","volume":"68","author":"T Mimori","year":"1981","unstructured":"Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M . Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 1981; 68: 611\u2013620.","journal-title":"J Clin Invest"},{"key":"BFbcj201235_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000133635","volume":"65","author":"QQ Cai","year":"1994","unstructured":"Cai QQ, Plet A, Imbert J, Lafage-Pochitaloff M, Cerdan C, Blanchard JM . Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. Cytogenet Cell Genet 1994; 65: 221\u2013227.","journal-title":"Cytogenet Cell Genet"},{"key":"BFbcj201235_CR32","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/S0021-9258(18)53216-6","volume":"268","author":"PR Blier","year":"1993","unstructured":"Blier PR, Griffith AJ, Craft J, Hardin JA . Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks. J Biol Chem 1993; 268: 7594\u20137601.","journal-title":"J Biol Chem"},{"key":"BFbcj201235_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0092-8674(93)90057-W","volume":"72","author":"TM Gottlieb","year":"1993","unstructured":"Gottlieb TM, Jackson SP . The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 1993; 72: 131\u2013142.","journal-title":"Cell"},{"key":"BFbcj201235_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1084\/jem.186.6.921","volume":"186","author":"H Ouyang","year":"1997","unstructured":"Ouyang H, Nussenzweig A, Kurimasa A, Soares VC, Li X, Cordon-Cardo C et al. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med 1997; 186: 921\u2013929.","journal-title":"J Exp Med"},{"key":"BFbcj201235_CR35","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1126\/science.8073286","volume":"265","author":"GE Taccioli","year":"1994","unstructured":"Taccioli GE, Gottlieb TM, Blunt T, Priestley A, Demengeot J, Mizuta R et al. Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 1994; 265: 1442\u20131445.","journal-title":"Science"},{"key":"BFbcj201235_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0092-8674(00)80111-7","volume":"86","author":"C Zhu","year":"1996","unstructured":"Zhu C, Bogue MA, Lim DS, Hasty P, Roth DB . Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 1996; 86: 379\u2013389.","journal-title":"Cell"},{"key":"BFbcj201235_CR37","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1073\/pnas.94.15.8076","volume":"94","author":"Y Gu","year":"1997","unstructured":"Gu Y, Jin S, Gao Y, Weaver DT, Alt FW . Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci USA 1997; 94: 8076\u20138081.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201235_CR38","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1073\/pnas.110152897","volume":"97","author":"DO Ferguson","year":"2000","unstructured":"Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA 2000; 97: 6630\u20136633.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201235_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/35006670","volume":"404","author":"MJ Difilippantonio","year":"2000","unstructured":"Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000; 404: 510\u2013514.","journal-title":"Nature"},{"key":"BFbcj201235_CR40","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V92.7.2213","volume":"92","author":"C Muller","year":"1998","unstructured":"Muller C, Christodoulopoulos G, Salles B, Panasci L . DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards. Blood 1998; 92: 2213\u20132219.","journal-title":"Blood"},{"key":"BFbcj201235_CR41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0960-9822(99)80311-X","volume":"9","author":"E Riballo","year":"1999","unstructured":"Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 1999; 9: 699\u2013702.","journal-title":"Curr Biol"},{"key":"BFbcj201235_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R Kuppers","year":"2005","unstructured":"Kuppers R . Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005; 5: 251\u2013262.","journal-title":"Nat Rev Cancer"},{"key":"BFbcj201235_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1172\/JCI16774","volume":"111","author":"D Moshous","year":"2003","unstructured":"Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana-Calvo M, Romana S et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 2003; 111: 381\u2013387.","journal-title":"J Clin Invest"},{"key":"BFbcj201235_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jmg.39.12.900","volume":"39","author":"PL Roddam","year":"2002","unstructured":"Roddam PL, Rollinson S, O'Driscoll M, Jeggo PA, Jack A, Morgan GJ . Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination. J Med Genet 2002; 39: 900\u2013905.","journal-title":"J Med Genet"},{"key":"BFbcj201235_CR45","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1182\/blood-2005-01-026690","volume":"108","author":"DA Hill","year":"2006","unstructured":"Hill DA, Wang SS, Cerhan JR, Davis S, Cozen W, Severson RK et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 2006; 108: 3161\u20133167.","journal-title":"Blood"},{"key":"BFbcj201235_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1600-0609.2005.00428.x","volume":"74","author":"TY Chen","year":"2005","unstructured":"Chen TY, Chen JS, Su WC, Wu MS, Tsao CJ . Expression of DNA repair gene Ku80 in lymphoid neoplasm. Eur J Haematol 2005; 74: 481\u2013488.","journal-title":"Eur J Haematol"},{"key":"BFbcj201235_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2004.02.001","volume":"77","author":"A Holgersson","year":"2004","unstructured":"Holgersson A, Erdal H, Nilsson A, Lewensohn R, Kanter L . Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies. Exp Mol Pathol 2004; 77: 1\u20136.","journal-title":"Exp Mol Pathol"},{"key":"BFbcj201235_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2141.2010.08088.x","volume":"149","author":"PL Roddam","year":"2010","unstructured":"Roddam PL, Allan JM, Dring AM, Worrillow LJ, Davies FE, Morgan GJ . Non-homologous end-joining gene profiling reveals distinct expression patterns associated with lymphoma and multiple myeloma. Br J Haematol 2010; 149: 258\u2013262.","journal-title":"Br J Haematol"},{"key":"BFbcj201235_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-8722-3-38","volume":"3","author":"A Sacco","year":"2010","unstructured":"Sacco A, Issa GC, Zhang Y, Liu Y, Maiso P, Ghobrial IM et al. Epigenetic modifications as key regulators of Waldenstrom\u2019s Macroglobulinemia biology. J Hematol Oncol 2010; 3: 38.","journal-title":"J Hematol Oncol"},{"key":"BFbcj201235_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","volume":"17","author":"AL Shaffer","year":"2002","unstructured":"Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A et al. Blimp1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17: 51\u201362.","journal-title":"Immunity"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj201235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj201235","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:41:49Z","timestamp":1672958509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,7]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9]]}},"alternative-id":["BFbcj201235"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2012.35","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,7]]},"assertion":[{"value":"28 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}